Insulin resistance in the HIV-lipodystrophy syndrome

被引:41
作者
Grinspoon, S [1 ]
机构
[1] Massachusetts Gen Hosp, Neuroendocrine Unit, Boston, MA 02114 USA
关键词
D O I
10.1016/S1043-2760(01)00472-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Insulin resistance is increasingly recognized among HIV-infected patients with fat redistribution (lipodystrophy) who are receiving highly active antiretroviral therapy. The mechanisms of insulin resistance in this population remain unknown, but could relate to a decrease in glucose transport caused by the direct effects of certain antiretroviral agents, such as the protease inhibitors, or to the effects of severe fat redistribution, including subcutaneous fat loss and increased visceral adiposity. Insulin resistance in patients with HIV lipodystrophy is associated with hyperlipidemia and impaired fibrinolysis, and might increase the risk of cardiovascular disease (CVD). Furthermore, insulin-sensitizing agents might improve insulin resistance and reduce the risk of CVD in this population.
引用
收藏
页码:413 / +
页数:7
相关论文
共 33 条
[1]   Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes [J].
Arioglu, E ;
Duncan-Morin, J ;
Sebring, N ;
Rother, KI ;
Gottlieb, N ;
Lieberman, J ;
Herion, D ;
Kleiner, DE ;
Reynolds, J ;
Premkumar, A ;
Sumner, AE ;
Hoofnagle, J ;
Reitman, ML ;
Taylor, SI .
ANNALS OF INTERNAL MEDICINE, 2000, 133 (04) :263-274
[2]   The HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localization, inhibits preadipocyte differentiation, and induces insulin resistance [J].
Caron, M ;
Auclair, R ;
Vigouroux, C ;
Glorian, M ;
Forest, C ;
Capeau, J .
DIABETES, 2001, 50 (06) :1378-1388
[3]   A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors [J].
Carr, A ;
Samaras, K ;
Burton, S ;
Law, M ;
Freund, J ;
Chisholm, DJ ;
Cooper, DA .
AIDS, 1998, 12 (07) :F51-F58
[4]   Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance [J].
Carr, A ;
Samaras, K ;
Chisholm, DJ ;
Cooper, DA .
LANCET, 1998, 351 (9119) :1881-1883
[5]   Hyperinsulinemia as an independent risk factor for ischemic heart disease [J].
Despres, JP ;
Lamarche, B ;
Mauriege, P ;
Cantin, B ;
Dagenais, GR ;
Moorjani, S ;
Lupien, PJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (15) :952-957
[6]   Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice [J].
Gavrilova, O ;
Marcus-Samuels, B ;
Graham, D ;
Kim, JK ;
Shulman, GI ;
Castle, AL ;
Vinson, C ;
Eckhaus, M ;
Reitman, ML .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (03) :271-278
[7]   Soluble receptors for tumor necrosis factor are markers for clinical course but not for major metabolic changes in human immunodeficiency virus infection [J].
Godfried, MH ;
Romijn, JA ;
vanderPoll, T ;
Weverling, GJ ;
Corssmit, EPM ;
Endert, E ;
Schattenkerk, JKE ;
Sauerwein, HP .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1995, 44 (12) :1564-1569
[8]   Fasting hyperinsulinemia in human immunodeficiency virus-infected men: Relationship to body composition, gonadal function, and protease inhibitor use [J].
Hadigan, C ;
Corcoran, C ;
Stanley, T ;
Piecuch, S ;
Klibanski, A ;
Grinspoon, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (01) :35-41
[9]   Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy [J].
Hadigan, C ;
Meigs, JB ;
Corcoran, C ;
Rietschel, P ;
Piecuch, S ;
Basgoz, N ;
Davis, B ;
Sax, P ;
Stanley, T ;
Wilson, PWF ;
D'Agostino, RB ;
Grinspoon, S .
CLINICAL INFECTIOUS DISEASES, 2001, 32 (01) :130-139
[10]   Metformin in the treatment of HIV lipodystrophy syndrome - A randomized controlled trial [J].
Hadigan, C ;
Corcoran, C ;
Basgoz, N ;
Davis, B ;
Sax, P ;
Grinspoon, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (04) :472-477